Nathanael Benitez
Family Medicine · Laurens, SCNPI 1346622883
Payments from drug & device makers
Across 108 payments — averaging $15.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$237
- Novo Nordisk$207
- Novartis$124
- Otsuka America Pharmaceutical, Inc.$122
- AstraZeneca$122
- Lilly USA, LLC$78
- plus $740 from 26 others
What the payments were for
- Food & beverage$1,629100%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 16 | $237 |
| Novo Nordisk | 15 | $207 |
| Novartis | 9 | $124 |
| Otsuka America Pharmaceutical, Inc. | 6 | $122 |
| AstraZeneca | 7 | $122 |
| Lilly USA, LLC | 5 | $78 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $77 |
| Sanofi-aventis U.S. LLC | 4 | $69 |
| AbbVie(2 entities) | 5 | $66 |
| Pfizer | 5 | $59 |
| VBI Vaccine (delaware) Inc. | 2 | $44 |
| Phadia US Inc. | 2 | $35 |
| Biogen | 2 | $34 |
| Esperion Therapeutics, Inc. | 2 | $30 |
| Amarin Pharma, Inc. | 2 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $26 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| E.r. Squibb & Sons, L.L.C. | 2 | $25 |
| Eyevance Pharmaceuticals LLC | 1 | $23 |
| Hikma Pharmaceuticals USA | 1 | $23 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $20 |
| Forte Bio-pharma LLC | 1 | $19 |
| Cvrx, Inc. | 4 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Stryker | 1 | $15 |
| Abbott | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Amgen | 1 | $13 |
| Bayer | 1 | $13 |
| Eisai Inc. | 1 | $13 |
| Sumitomo Pharma America, Inc. | 1 | $1 |
How this compares
$1,630 in reported general payments places this provider in the 65th percentile of 2,153 family medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 186 | $100,185 |
| JardianceEmpagliflozin | 147 | $87,820 |
| MounjaroTirzepatide | 52 | $77,593 |
| OzempicSemaglutide | 30 | $27,223 |
| FarxigaDapagliflozin Propanediol | 22 | $24,449 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 36 | $23,457 |
| TrulicityDulaglutide | 21 | $21,233 |
| MyrbetriqMirabegron | 37 | $19,417 |
| XareltoRivaroxaban | 24 | $18,045 |
| RexultiBrexpiprazole | 23 | $16,777 |
| Tresiba Flextouch U-100Insulin Degludec | 17 | $13,434 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 16 | $9,963 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $7,337 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 74 | $7,139 |
| Atorvastatin Calcium | 551 | $6,103 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $59 | $100,185186 claims |
| Lilly USA, LLCMounjaro, Trulicity | $78 | $98,82673 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort, Brilinta | $122 | $42,85883 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $237 | $28,82648 claims |
| Novo NordiskOzempic | $207 | $27,22330 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $122 | $16,77723 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $26 | $4,13332 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,153 family medicine providers in South Carolina.
Other family medicine in Laurens
- Cayce TangemanGoose Creek$8.4M
- Jeremy AckermannMoncks Corner$7.6M
- Kelly MoralesNorth Charleston$6.5M
- William ByarsGreer$4.8M
- James FranklinGreenville$3.5M
- Stephen GrubbLittle River$3.4M
- Jeffrey HarrisGreenville$3.4M
- Shannon ConradN Charleston$3.3M
- Tom ChristensenLittle River$3.1M
- Edward NewtonCharleston$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.